CVRx Insider Buy Signals Confidence as VFMS Nears FDA Approval
Investor insight: Jain Mudit K’s recent CVRx buy signals confidence amid a steep 60% slide, as the VFMS device shows promising Phase‑II results that could spark FDA clearance and a market rebound.
4 minutes to read